SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea · Delayed Price · Currency is KRW 83,700
-2,800 (-3.24%)
Aug 21, 2026, 3:30 PM KST
SK Biopharmaceuticals Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, SK Biopharmaceuticals stock has a consensus rating of "Buy" and an average price target of ₩128,667. The average 1-year stock price forecast is 53.72% higher than the current stock price, while the lowest is ₩74,000 (-11.59%) and the highest is ₩160,000 (+91.16%).
Price Target: ₩128,667 (+53.72%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for SK Biopharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 7 | 7 | 5 | 5 | 5 |
| Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 14 | 13 | 13 | 11 | 12 | 12 |
Financial Forecast
Revenue This Year
978.45B
from 706.74B
Increased by 38.45%
Revenue Next Year
1.15T
from 978.45B
Increased by 17.81%
EPS This Year
4.26K
from 3.41K
Increased by 24.86%
EPS Next Year
5.24K
from 4.26K
Increased by 23.06%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.